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Background. The aim of this study is to evaluate the safety and sufficiency of a fixed dose
rate propofol infusion for repeated prolonged deep sedation in children for proton radiation
therapy (PRT).
Methods. With ERB approval, we recorded anaesthesia monitoring data in children under-
going repeated prolonged propofol sedation for PRT. Sedation was introduced with a single
bolus of i.v. midazolam 0.1 mg kg21 followed by repeated small boluses of propofol until suffi-
cient depth of sedation was obtained. Sedation was maintained with fixed dose rate propofol
infusion of 10 mg kg21 h21 in all patients up to the end of the radiation procedure. Patient
characteristics, number and duration of sedation, propofol induction dose, necessity to alter
propofol infusion rate, and heart rate, mean arterial pressure, respiratory rate were noted at
the end of the radiation procedure before cessation of the propofol infusion. Data are mean
(SD) or range (median) as appropriate.
Results. Eighteen children aged from 1.4 to 4.2 yr (2.6 yr) had 27.6 (SD 2.0) (497 in total) radi-
ation procedures within 44.1 (4.0) days lasting 55.7 (8.8) min. Propofol bolus dose for induc-
tion, monitoring, and positioning was 3.7 (1.0) mg kg21. Propofol bolus requirements were
quite stable over the successive weeks of treatment and variability was larger between individ-
uals than over time. In none of the children did propofol infusion rate need to be changed
from the pre-set 10 mg kg21 h21 flow rate because of haemodynamic state, respiratory
conditions or inadequate anaesthesia.
Conclusions. Repeated prolonged deep sedation over several weeks in very young children
using a fixed rate propofol infusion was safe and adequate for all patients.
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Proton radiation therapy (PRT) is a highly conformal radi-
ation technique offering the advantage of precisely depositing
the energy within the target volume and sparing non-target
tissues.1 This reduces the risk of secondary cancer and normal
tissue damage, being of particular interest in children.2
Conformal radiation techniques require precise positioning of
the patient, and additional positioning check-ups are per-
formed before each radiation procedure. Therefore, PRT is a
somewhat more time-consuming procedure than conventional
radiotherapy, prolonging the time of sedation required.
During proton radiation, no personnel are allowed to be
with the patient, and syringe pumps in the treatment room
cannot be manipulated to adapt the hypnotic drug dose.
Therefore, a safe and sufficient sedation technique for
immobilization and stable cardio-respiratory conditions is
required while the patient is observed by television
cameras from a long distance. Repeated exposure to seda-
tive drugs that depress the central nervous system is
associated with the development of tolerance,3 4 which
may complicate appropriate dosing of sedative drugs
under these challenging conditions.
Propofol is an interesting hypnotic drug to provide seda-
tion for diagnostic procedures in young patients. It is
increasingly used for children undergoing repeated
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radiation procedures, since it provides reliable sedation,
short recovery periods, and early hospital discharge.5
The aim of this study is to evaluate the safety and
sufficiency of a fixed dose rate propofol infusion in spon-
taneously breathing children undergoing repeated prolonged
deep propofol sedation for proton radiation over several
weeks.
Methods
With hospital ethical committee approval (University
Children’s Hospital Zurich, Switzerland), we recorded
anaesthesia monitoring data in children undergoing
PRT under deep propofol sedation in the Division of
Radiotherapy, Paul Scherrer Institut (PSI), Villigen,
Switzerland. Patients receiving opioids or sedative drugs
other than those suggested by the treatment protocol were
excluded from the study.
The PSI is a Swiss National Physics Centre with a
cyclotron providing high-energy protons for radiation
therapy. The paediatric anaesthesia service in the PSI,
located 50 km from the University Children’s Hospital
Zurich, is provided by four paediatric consultant anaesthe-
tists of our department.
All patients had a permanent pre-existing indwelling
central venous catheter or an implanted infusion system
(Port-a-Cath) inserted. Patients had four radiation pro-
cedures a week with a break on Wednesday and during the
weekend. Sedation was performed according to our stan-
dard institutional sedation protocol for immobilization of
children for magnetic resonance imaging. Children were
fasted for 4 h for solids and fluids and for 2 h for clear
fluids, and did not receive premedication before induction.
Sedation was introduced with a single bolus of i.v. mida-
zolam 0.1 mg kg21 followed by repeated small i.v.
boluses of propofol ranging between 0.5 and 1 mg kg21
until sufficient depth of sedation was obtained within 1–2
min for monitoring, including tolerance to nasal prongs,
and to make the child motionless during positioning
(about 5–10 min after induction) by the radio-therapist.
Sedation was maintained with a fixed rate dose propofol
infusion (10 mg kg21 h21) in all patients up to the end of
the radiation procedure. SpO2 monitoring was started
before induction; ECG, non-invasive arterial pressure
measurement, and nasal prongs for nasal CO2 sampling
and for application of oxygen were installed immediately
after induction.
Deep sedation and monitoring was started in the anaes-
thesia induction room. Then the patients were transferred
on a trolley to the imaging room. In the imaging room, the
patients were positioned on the mobile treatment table in a
whole body vacuum mould with bite block or mask immo-
bilization of the head in either the supine or prone pos-
ition. Additional positioning checks are performed at the
PSI through imaging before each radiation procedure.
After confirmation of proper agreement of actual with
initial position, the patients were transferred on the treat-
ment table to the proton therapy unit (proton gantry).
Radiation therapy was performed without personnel in the
proton gantry (Fig. 1). Patients were continuously moni-
tored for arterial pressure at 5 min intervals, heart rate
(HR) by ECG, and respiratory rate (RR) by means of E0CO2
trace and SpO2. Patients were observed by means of video
cameras for inadvertent movements in the proton gantry
and vital sign data were transmitted to a monitor screen in
the control room, located 15 m away from the proton
gantry. After radiation, patients were moved from the
vacuum mould in their personal bed and brought into the
recovery room.
Patient characteristics, number and duration (time from
induction of sedation until cessation of propofol infusion)
of sedation were noted. The total amount of propofol
required for induction, application of monitoring and
patient positioning was noted. RR, HR, systolic arterial
pressure, diastolic arterial pressure were recorded at the
end of the procedure before cessation of the continuous
propofol infusion. Propofol induction bolus dose required
and necessity to alter propofol infusion rate because of
insufficient sedation or cardio-respiratory depression were
noted; mean arterial pressure (MAP) was calculated from
systolic and diastolic pressures for presentation and further
calculations. Propofol bolus dose, MAP, HR, SpO2 and RR
were averaged [mean (SD)] for each week of therapy. Data
are mean (SD) or range (median) as appropriate.
Results
Eighteen children (13 girls and 5 boys) aged from 1.4 to
4.2 yr (median 2.6 yr) undergoing PRT at the PSI were
included in the observational study. One girl with a
Fig 1 A 2.6-yr-old child under deep propofol sedation for proton therapy
in the prone position placed in the whole body mould with the head
immobilized by means of a head mask (arrow).
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tracheostomy cannula had to be excluded from the study
as she needed opioids because of coughing due to copious
secretion. They had 27.6 (2.0) (497 in total) radiation pro-
cedures within 44.1 (4.0) days. Each period of sedation
lasted 55.7 (8.8) min and total sedation time was 25.6
(4.4) h per patient.
The fixed rate dose propofol infusion of 10 mg kg21
h21 was sufficient in all patients to avoid inadvertent
movements and to guarantee safe cardio-respiratory con-
ditions. SpO2 values with 2 litres of oxygen at the nose
ranged from 95% to 100% (median 99.3%). No additional
propofol boluses were needed after final positioning until
the end of the radiation procedure. The average propofol
bolus dose for induction and patient positioning was 3.7
(1.0) mg kg21. Requirements of propofol induction dose
were quite stable over the successive weeks of treatment
(Table 1) and variability was larger between individuals
than over time (Fig. 2). In none of the children did the
propofol infusion rate need to be changed from the pre-set
10 mg kg21 h21 flow rate because of haemodynamic state,
respiratory conditions or inadequate anaesthesia, although
many of them suffered from local and systemic infections,
weight loss, exhaustion, and intra-cerebral hypertension
or received drug therapies and parenteral nutrition.
Haemodynamic and respiratory variables measured at the
end of the radiation procedure after at least 30 min of
unchanged steady-state infusion of propofol demonstrated
considerable inter-individual differences between different
weeks of therapy, but on average they were stable over the
treatment period of 7 weeks PRT (Fig. 3).
Discussion
Young children with malignancies requiring repeated radi-
ation therapy usually need general anaesthesia or deep
sedation. Because of its pharmacological profile, propofol
is an excellent hypnotic drug for short procedures in
young children. It allows reliable sedation and immobiliz-
ation with spontaneous ventilation, and has been reported
to be safe and appropriate for repeated conventional radi-
ation procedures in children.5–7
In this study, we evaluated the safety and sufficiency of
a fixed dose rate propofol infusion for repeated, prolonged
propofol sedation in spontaneously breathing children
undergoing PRT. The main finding was that a fix rate dose
propofol infusion of 10 mg kg21 h21 was sufficient in all
patients to provide safe cardio-respiratory conditions and
to avoid inadvertent movements during the prolonged
proton radiation procedure.
Propofol sedation in children is routinely used for diag-
nostic procedures such as magnetic resonance imaging or
computed tomography and other imaging procedures.
Normally, these procedures are short, not very often
repeated and personal attendance or immediate access to
the patient is possible in order to adapt depth of sedation
or to provide cardio-respiratory support if needed. In this
setting, the individual continuous infusion dose for propo-
fol can be titrated to a desired level of sedation.
PRT is a time-consuming procedure similar to highly
conformal or multiple-field radio-therapeutic procedures.
Patient’s induction, immobilization, the transportation to
the imaging room and to the treatment room, patient posi-
tioning for control imaging before each radiation pro-
cedure, as used at the PSI, and the proton radiation itself
resulted in a mean duration for sedation of almost 1 h and
in a total sedation time of 25.6 h during 6–7 weeks. For
PRT as a highly precise radiation technique, a sufficient
level of deep sedation is required to avoid inadvertent
Table 1 Propofol bolus required for induction and final patient positioning, HR, MAP, and RR, measured at the end of the radiation procedure and duration of
the sedation procedure. Data are mean (SD). (n¼18 children, four sedations per week)
Number of week
1 2 3 4 5 6 7
Propofol bolus
(mg kg21)
3.8 (1.2) 3.9 (1.1) 3.7 (0.9) 3.7 (0.9) 3.6 (0.9) 3.6 (0.9) 3.4 (1.2)
HR (beats min21) 98.5 (15.8) 98.5 (11.7) 96.6 (10.8) 97.1 (10.7) 97.7 (11.7) 96.4 (11.0) 97.9 (11.6)
MAP (mm Hg) 54.2 (7.5) 54.6 (7.1) 53.5 (5.9) 52.8 (6.2) 53.7 (6.5) 54.0 (5.7) 53.8 (6.0)
RR (bpm) 25.3 (4.5) 25.2 (5.0) 25.2 (4.3) 25.4 (4.1) 25.9 (5.2) 25.9 (4.7) 26.0 (3.5)
Duration (min) 64.9 (21.4) 58.1 (13.6) 53.1 (12.6) 55.7 (16.8) 54.7 (16.3) 52.9 (18.2) 50.5 (12.6)
Fig 2 Individual and averaged amount of propofol (mg kg21) required
for induction and patient positioning for each week of therapy (n
patients¼18; n procedures¼497).
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movement of the patient after positioning until the end of
the radiation procedure since there is no access to the
patient or to the infusion pump in the proton gantry
without interruption of the radiation procedure. Any move-
ments of the patient after the imaging procedure (transfer
to the proton gantry or during proton radiation) would
result in a break in the radiation procedure and would
require re-confirmation of the correct patient positioning
by imaging and restarting the radiation protocol. In
addition, cardio-respiratory stability is another challenge,
particularly in these children with weakened physical state
(due to chemotherapeutic drugs, infections, sepsis, parent-
eral nutrition, exhaustion and loss of weight) and, on the
other hand, in the child without a protected airway, the
head restricted in a face mask and in the prone position
(Fig. 1). Our data, obtained from 18 patients undergoing
almost 500 prolonged sedation procedures, demonstrate
that a fixed dose rate of propofol infusion of 10 mg kg21
h21 was able to provide a sufficient level of sedation and
immobilization as well as stable conditions in all patients
and procedures. Scheiber and colleagues5 used a 10 mg
kg21 h21 propofol infusion rate and then a reduced dose
rate of 7.4 (2.2) mg kg21 h21 propofol was used, as
allowed by immobilization. However, these procedures did
not include highly conformal radiation techniques, were
much shorter [18 (11) min], and easy access to the patient
was guaranteed.
Overall, the induction dose in our study population was
similar to that reported by Scheiber and colleagues.5 In
contrast to other authors using a fixed dose of propofol for
induction,8 with the presented technique the induction
dose was titrated until sufficient depth of sedation was
obtained. The rationale to titrate the propofol induction
dose daily is to avoid propofol overdosage necessitating
respiratory and haemodynamic support because of vari-
ations in tiredness, sedation and sometimes intracranial
hypertension, other drug therapies and current infectious
diseases, including sepsis requiring different induction
doses (Fig. 2). Intra-individual variation in propofol
requirements may additionally be related to various
degrees of anxiety, previous puncture of the Port-a-Cath
system, and differing reactions of the child to changing
anaesthesia teams. The different physical and anxiety con-
ditions may explain intra-individual weekly differences in
recorded cardio-respiratory parameters with a fixed rate
dose propofol infusion protocol over several weeks. It can
be argued that monitoring the depth of anaesthesia would
allow us to adapt propofol to a desired level of anaesthesia
and to avoid a fixed rate dose propofol infusion. We did
not use the bispectral index or another cerebral function
monitor to give an objective measure of depth of sedation
in our patients because of technical (mobility), positional
(Fig. 1) and logistic barriers to using such monitors in the
PRT setting and, as mentioned earlier, titration was not
possible as the syringe pump could not be manipulated in
the proton gantry.
To date, there are no clinical studies investigating toler-
ance to propofol in children undergoing repeated pro-
longed deep sedation. Usually, sedation for conventional
radiation procedures lasts about 15–20 min, including
monitoring and patient positioning. So far, no tolerance
during induction for repeated propofol sedation in
children was reported for repeated short-term propofol
sedation,5 8–10 except in one child requiring up to 16-fold
the propofol dose compared with the first session, probably
caused by pharmacodynamic tolerance.11 In our study
population, in none of the patients treated was an increase
of induction dose or continuous propofol infusion required
over time. Nevertheless, our data do not scientifically
exclude the development of tolerance to propofol, since
Fig 3 Individual and averaged HR, MAP, and RR noted at the end
of each radiation procedure for each week of therapy (n patients¼18;
n procedures¼497).
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preoperative anxiety and sedation scores and other factors
such as intracranial pressure, infections, drug therapies,
parenteral nutrition, and patient’s exhaustion affect sensi-
tivity to hypnotic drugs. Secondly, the therapeutic window
for propofol is wide in children and, without using a cer-
ebral function monitor, there is no way to be sure that half
the dose or double the dose would not provide the same
stability.
Recently, sevoflurane has been successfully used by
different authors for sedation of small children undergoing
magnetic resonance imaging.12 13 This approach is excel-
lent in children without venous access, since sedation is
introduced and maintained simply by nasal insufflation.
Awakening from sevoflurane sedation is rapid. However,
transient excessive emergence agitation and vomiting have
been described in up to 12% and 5%, respectively, of the
patients, both of which are extremely rare after propofol
sedation. Small children presenting for repeated radiation
procedures usually have a central venous access implanted
for i.v. induction, which is more comfortable than installa-
tion of a mask, a nasal tube or nasal prongs. Deepening
anaesthesia for manipulation or positioning is easier and
faster with i.v. boluses of propofol than by increasing
sevoflurane concentration via the patient’s nose. Secondly,
environmental pollution of sevoflurane may become a
problem in radiation theatres, where air conditioning is
probably not always like that in an operating theatre.
Thirdly, from a technical stand point, a syringe pump, in
contrast to a sevoflurane vaporizer is easier to move with
the patients through the different places during PRT and is
a commercially provided stand-alone system without the
need for an anaesthesia respirator. Finally, laboratory and
clinical data are required for repeated daily sevoflurane
applications before this approach is routinely used in
paediatric radiation therapy.
In conclusion, repeated prolonged deep sedation for pro-
pofol radiation over several weeks in very young spon-
taneously breathing children using a small dose of
midazolam and titrated propofol for induction followed by
a fixed dose rate propofol infusion of 10 mg kg21 h21 for
maintenance was safe and adequate. The presented seda-
tion technique offered stable cardio-respiratory conditions
and sufficient patient immobilization during repeated radi-
ation procedures in the proton gantry.
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